Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:38 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 217–240 of 398 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: hemoglobin A1c Clear all

Conditions: Diabetes Mellitus, Vitamin D Deficiency
Interventions: Vitamin D; Dietary Supplement
Lead sponsor: Ascension Health; Industry
Eligibility: 34 Years to 69 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Flint, Michigan

Conditions: Diabetes, Type 1, Diabetes, Type 2, Foot Ulcer, Diabetic
Interventions: Bacitracin, AmeriGel®, Vitamin C; Drug · Dietary Supplement
Lead sponsor: Susan Hassenbein; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Metabolic Syndrome
Interventions: Promotora plus standard physical screening exam , hemoglobin A1c levels, lipid panels, fasting glucose, height, weight, BMI, Complete Blood Count; Behavioral
Lead sponsor: Family Medicine Residency of Idaho; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 3
States / cities: Caldwell, Idaho • Jerome, Idaho • Nampa, Idaho

Conditions: Type 1 Diabetes Mellitus, Glycemic Control
Interventions: Bayer DCA2000+ Hemoglobin A1c analyzer; Device
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 2 Years to 18 Years
Enrollment: 234 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Diabetes, Liver Transplant; Complications, Kidney Transplant Failure
Interventions: hemoglobin A1c; Diagnostic Test
Lead sponsor: Methodist Health System; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Type 1 Diabetics Who Are Pregnant or Planning Pregnancy
Interventions: CGM; Device
Lead sponsor: Mount Sinai Hospital, Canada; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 325 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Santa Barbara, California

Conditions: Pregnant, Postpartum
Interventions: Point of care device to measure HbA1c; Diagnostic Test
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Type 2 Diabetes
Interventions: FINANCE-DM, Active Comparator; Behavioral
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 21 Years and older
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Pulmonary Disease, Chronic Obstructive, Osteoporosis
Interventions: Vital signs, Urine Pregnancy Test, Questionnaires, Blood Test, Duel-energy X-ray absorptiometry scan, Multi-detector computed tomography, Dual-energy X-ray absorptiometry scan; Diagnostic Test · Other
Lead sponsor: Punam K Saha; Other
Eligibility: 45 Years to 90 Years
Enrollment: 560 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2025
U.S. locations: 2
States / cities: Iowa City, Iowa • New York, New York

Conditions: Diabetes Mellitus, Type 2
Interventions: Dexcom G6, Contour NextOne; Device
Lead sponsor: Intermountain Health Care, Inc.; Other
Eligibility: 18 Years to 80 Years
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 4
States / cities: Holladay, Utah • Murray, Utah • Salt Lake City, Utah

Conditions: Diabetic Retinopathy
Interventions: Hypoglycemic Agents, Standard glycemia control, Intensive BP treatment, Standard BP control, Fenofibrate, Simvastatin, Placebo; Drug
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 40 Years to 79 Years
Enrollment: 3,472 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2009
U.S. locations: 6
States / cities: Minneapolis, Minnesota • New York, New York • Winston-Salem, North Carolina + 3 more

Conditions: Diet, Healthy, HbA1c, Blood Pressure
Interventions: Medically Tailored Groceries; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 20 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Breast Cancer, Early-stage Breast Cancer
Interventions: Prescreening, Screening and Enrollment, Baseline, Interpret BMI, Interpret HbA1c, Interpret lipid panel and assess other risk factors, Assess 10 year risk of cardiovascular event, Recommendations, Follow-Up; Other · Behavioral
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Diabetes Mellitus, Type 2
Interventions: Glimepiride, Canagliflozin (JNJ-28431754), Metformin; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 1,452 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 43
States / cities: Calera, Alabama • Gilbert, Arizona • Mesa, Arizona + 40 more

Conditions: Type 2 Diabetes
Interventions: telephonic; Behavioral
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 18 Years to 85 Years
Enrollment: 941 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: New York, New York

Conditions: Prediabetes, Diabetes, High Cholesterol/Hyperlipidemia, Obesity & Overweight, Triglycerides, HDL Cholesterol
Interventions: Bottarga, Comparator; Other
Lead sponsor: Cambridge Health Alliance; Other
Eligibility: 18 Years to 60 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Sommerville, Massachusetts

Conditions: Diabetes
Interventions: cinnamon; Drug
Lead sponsor: Eglin AFB Regional Hospital; Federal
Eligibility: 18 Years to 90 Years
Enrollment: 109 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007
U.S. locations: 1
States / cities: Eglin Air Force Base, Florida

Conditions: Type 2 Diabetes Mellitus
Interventions: HE3286, Placebo; Drug
Lead sponsor: Harbor Therapeutics; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 164 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 22
States / cities: Anaheim, California • Beverly Hills, California • Buena Park, California + 17 more

Conditions: PreDiabetes
Interventions: Transform10 Diabetes Prevention Program; Other
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 18 Years to 64 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Diabetes Mellitus, Type 2, Diabetes
Interventions: Metformin, Detemir, Liraglutide, Insulin Aspart; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 157 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Type 2 Diabetes
Interventions: vitamin D3, cholecalciferol, Inactive comparator; Dietary Supplement
Lead sponsor: Augusta University; Other
Eligibility: 19 Years to 60 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Type 2 Diabetes
Interventions: Mulberry Leaf Extract, Placebo; Drug
Lead sponsor: University of Mississippi Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Jackson, Mississippi

Conditions: Diabetes Mellitus, Type 2
Interventions: Canagliflozin 50 mg, Placebo, Canagliflozin 150 mg, Metformin; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 279 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 26
States / cities: Little Rock, Arkansas • National City, California • Spring Valley, California + 23 more

Conditions: Pre-Diabetes, Diabetes, Cardiovascular Risks
Interventions: Not listed
Lead sponsor: Mike O'Callaghan Military Hospital; Federal
Eligibility: 18 Years and older
Enrollment: 535 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Las Vegas, Nevada

Search by objective public record fields.

Effect of Vitamin D Supplementation on Hemoglobin A1c

The Relationship of Hemoglobin A1c and Diabetic Wound Healing

Utilizing a Promotora Model for Rural Adult Hispanics Diagnosed With Metabolic Syndrome: A Clinical Trial

Effect of Immediate Hemoglobin A1c on Glycemic Control in Children With Type I Diabetes Mellitus

Optimal A1c Control in Post Liver or Combined Liver and Kidney Transplant Recipients Who Have Diabetes Mellitus

Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial

Feasibility of Remote Data Collection With a Point of Care Device to Measure HbA1c

Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM)-1

CT-Based Modeling of Bone Micro-Architecture and Fracture-Risk in COPD

CGM - Reimagine Primary Care

Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study)

MTM2MTG Pilot Ancillary Study

Cardiometabolic Screening Program

CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride

Bronx A1c: Bring it Down for Health

Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food

Randomized Controlled Clinical Trial of Cinnamon to Lower Hemoglobin A1c

Safety, Tolerance and Activity of HE3286 in Patients With Type 2 Diabetes Mellitus

Digital Diabetes Prevention Program Study

The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study

The Effect of Vitamin D Supplementation on Glucose Metabolism in Non-Diabetic African American Adults

Impact of Mulberry Leaf on Type 2 Diabetes

An Efficacy, Safety, and Tolerability Study of Canagliflozin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy

A1c FIT TEST: An Epidemiological Study Correlating Hemoglobin A1c With Results of the Air Force Physical FITness TEST.